| Jacob Boston Hunter, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 645-8898 | |
| (214) 645-8894 |
| Full Name | Jacob Boston Hunter |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 15 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053644963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0901X | Otolaryngology - Otology & Neurotology | Q8264 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson University Physicians | 7911819180 | 1269 |
| Jefferson University Physicians Of New Jersey Pc | 9931325131 | 104 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011.
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.
Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.
Like homing pigeons, humans have a nose for navigation because our brains are wired to convert smells into spatial information, new research from the University of California, Berkeley, shows.
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
› Verified 6 days ago
| Entity Name | Jefferson University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326093675 PECOS PAC ID: 7911819180 Enrollment ID: O20040225000232 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011.
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.
Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.
Like homing pigeons, humans have a nose for navigation because our brains are wired to convert smells into spatial information, new research from the University of California, Berkeley, shows.
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Boston Hunter, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 645-8898 | Jacob Boston Hunter, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 645-8898 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011.
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.
Though researchers have made substantial progress in developing drug-ferrying nanoparticles that successfully target tumor cells in living animals, including humans, investigators have only now started the detailed work needed to identify formulation parameters that would optimize drug delivery to malignant cells.
Like homing pigeons, humans have a nose for navigation because our brains are wired to convert smells into spatial information, new research from the University of California, Berkeley, shows.
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
› Verified 6 days ago
Dr. Anthony Michael Tolisano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3102 | |
Presley M. Mock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8440 Walnut Hill Ln, Ste 500, Dallas, TX 75231 Phone: 214-345-1491 Fax: 214-345-5708 | |
Dr. Jane Farrar Admire, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Ln, Suite C-100, Dallas, TX 75230 Phone: 972-566-4848 | |
Chung-en Huang, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3430 W Wheatland Rd Ste 209, Dallas, TX 75237 Phone: 972-780-1496 Fax: 972-709-1496 | |
Dr. Seckin Omer Ulualp, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-2905 | |
Dr. Kenneth H Lee, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Ut Soutwestern Otolaryngology, Dallas, TX 45229 Phone: 214-648-2972 Fax: 214-648-9122 |